FEATURED ARTICLES
How does the cell and gene therapy supply chain team stay ahead of the expected changes and respond at the speed the developing program expects? Supplier selection, raw materials, built-in quality, warehousing and logistics, and traceability are all covered in this article.
-
Compelling Advantages Of Creating A Patient-Centric Supply Chain
Marken’s Nina Vas, discusses everything from global regulatory and trade compliance proficiency to the importance of a secure, closed-loop environment with regard to developing a patient-centric supply chain.
-
Accelerating Timelines By Planning For Clinical Supplies In Advance
Discover approaches in support of accelerated development timelines, including adopting a single vendor approach, engaging experts earlier in the development cycle, and performing timeline steps in parallel versus linearly.
-
Cell & Gene Therapies Require the Right Tracking Solution
In cell therapy trials, the ability to track a patient’s cells is essential. When you have over 100 patients, and the cells will require multiple shipments, using a spreadsheet is not possible. “For the safety of our patient, accurate tracking is a must,” says Gerald Garrett, VP of clinical operations for MarkerTherapeutics. “We need to know exactly where the product is at any step of the way.”